Burmester GR, Van den Bosch F, Tesser J, Shmagel A, et al. Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT). J Rheumatol 2024 Apr 15:jrheum.2023-1062. doi: 10.3899/jrheum.2023-1062.
PMID: 38621793